Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients.

Chen YH, Chen HS, Tarng DC.

Diabetes Care. 2012 Apr;35(4):803-8. doi: 10.2337/dc11-1955. Epub 2012 Feb 14.

2.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

4.

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).

Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE, Atkins RC.

Diabetes Care. 2009 Aug;32(8):1497-502. doi: 10.2337/dc08-2186. Epub 2009 May 26.

5.

Diabetic retinopathy and microalbuminuria can predict macroalbuminuria and renal function decline in Japanese type 2 diabetic patients: Japan Diabetes Complications Study.

Moriya T, Tanaka S, Kawasaki R, Ohashi Y, Akanuma Y, Yamada N, Sone H, Yamashita H, Katayama S; Japan Diabetes Complications Study Group.

Diabetes Care. 2013 Sep;36(9):2803-9. doi: 10.2337/dc12-2327. Epub 2013 Apr 25.

6.

Incidence and determinants of microalbuminuria in Koreans with type 2 diabetes.

Park JY, Kim HK, Chung YE, Kim SW, Hong SK, Lee KU.

Diabetes Care. 1998 Apr;21(4):530-4.

PMID:
9571337
7.

Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.

Viana LV, Gross JL, Camargo JL, Zelmanovitz T, da Costa Rocha EP, Azevedo MJ.

J Diabetes Complications. 2012 Sep-Oct;26(5):407-12. doi: 10.1016/j.jdiacomp.2012.04.014. Epub 2012 Jun 6.

PMID:
22677793
8.

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus.

Tong PC, Kong AP, So WY, Yang X, Ng MC, Ho CS, Ma RC, Ozaki R, Ng V, Chow CC, Lam CW, Chan JC, Cockram CS.

Diabet Med. 2007 Jul;24(7):741-6. Epub 2007 Apr 2.

PMID:
17403120
9.

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.

Estacio RO, Jeffers BW, Gifford N, Schrier RW.

Diabetes Care. 2000 Apr;23 Suppl 2:B54-64.

PMID:
10860192
10.

High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study.

Sasso FC, Chiodini P, Carbonara O, De Nicola L, Conte G, Salvatore T, Nasti R, Marfella R, Gallo C, Signoriello S, Torella R, Minutolo R; Nephropathy In Type 2 Diabetes Study Group.

Nephrol Dial Transplant. 2012 Jun;27(6):2269-74. doi: 10.1093/ndt/gfr644. Epub 2011 Nov 16.

PMID:
22090446
11.

Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes.

Araki S, Haneda M, Koya D, Hidaka H, Sugimoto T, Isono M, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A.

Diabetes. 2007 Jun;56(6):1727-30. Epub 2007 Mar 14.

12.

Visit-to-visit variability in systolic blood pressure predicts development and progression of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes.

Takao T, Matsuyama Y, Yanagisawa H, Kikuchi M, Kawazu S.

J Diabetes Complications. 2014 Mar-Apr;28(2):185-90. doi: 10.1016/j.jdiacomp.2013.11.003. Epub 2013 Nov 13.

PMID:
24332763
13.

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.

Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.

Diabetes Care. 2008 Apr;31(4):747-52. Epub 2007 Dec 27.

PMID:
18162497
15.

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

Kramer HJ, Nguyen QD, Curhan G, Hsu CY.

JAMA. 2003 Jun 25;289(24):3273-7.

PMID:
12824208
16.

Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjects.

Meguro S, Shigihara T, Kabeya Y, Tomita M, Atsumi Y.

Intern Med. 2009;48(9):657-63. Epub 2009 May 1.

17.

Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32).

Surendar J, Anuradha S, Ashley B, Balasubramanyam M, Aravindhan V, Rema M, Mohan V.

Metab Syndr Relat Disord. 2009 Oct;7(5):419-25. doi: 10.1089/met.2008.0084.

PMID:
19419268
18.

Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.

Sheen YJ, Lin JL, Li TC, Bau CT, Sheu WH.

J Diabetes Complications. 2014 Nov-Dec;28(6):779-84. doi: 10.1016/j.jdiacomp.2014.08.002. Epub 2014 Aug 16.

PMID:
25219331
19.

Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.

Tarnow L, Gall MA, Hansen BV, Hovind P, Parving HH.

Diabetologia. 2006 Oct;49(10):2256-62. Epub 2006 Aug 26.

PMID:
16937127
20.

Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.

Gaede P, Tarnow L, Vedel P, Parving HH, Pedersen O.

Nephrol Dial Transplant. 2004 Nov;19(11):2784-8. Epub 2004 Aug 24.

PMID:
15328385

Supplemental Content

Support Center